Global Neurovascular Devices Market 2022-2028

Abstract
Neurovascular or cerebrovascular disease refers to all disorders in which an area of the brain is temporarily or permanently affected by bleeding or restricted blood flow. Restrictions in blood flow may occur from vessel narrowing (stenosis), clot formation (thrombosis), blockage (embolism), or blood vessel rupture (hemorrhage). The global neurovascular devices market is anticipated to reach valuation of ~USD 4,590 million by 2028, representing a CAGR of 6.7% from 2022 to 2028 as per the latest report by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global neurovascular devices market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the neurovascular devices industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, application, end user, and region. The global market for neurovascular devices can be segmented by product: access devices (microcatheter, guidewire), angioplasty and stenting (carotid stenting, embolic protection systems), embolization devices (embolic coils, flow diverter, liquid embolic agent), thrombectomy devices (clot retrieval devices, suction & aspiration devices, snares). The embolization devices segment held the largest revenue share in 2021. Neurovascular devices market is further segmented by application: arteriovenous malformation and fistulas (AVM), cerebral aneurysm, cerebral artery stenosis, ischemic strokes, others. Based on end user, the neurovascular devices market is segmented into: ambulatory surgical centers (ASCs), hospitals, specialized clinics. On the basis of region, the neurovascular devices market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW).

By product:
- access devices (microcatheter, guidewire)
- angioplasty and stenting (carotid stenting, embolic protection systems)
- embolization devices (embolic coils, flow diverter, liquid embolic agent)
- thrombectomy devices (clot retrieval devices, suction & aspiration devices, snares)

By application:
- arteriovenous malformation and fistulas (AVM)
- cerebral aneurysm
- cerebral artery stenosis
- ischemic strokes
- others

By end user:
- ambulatory surgical centers (ASCs)
- hospitals
- specialized clinics

By region:
- Asia Pacific
- Europe
- North America
- Rest of the World (RoW)

The market research report covers the analysis of key stake holders of the global neurovascular devices market. Some of the leading players profiled in the report include EndoVasix Inc., Johnson & Johnson, Medtronic plc, MicroPort Scientific Corporation, MIVI Neuroscience, Inc., Oxford Endovascular Limited, Penumbra, Inc., Rapid Medical Ltd., Stryker Corporation, Terumo Corporation, among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
- To analyze and forecast the market size of the global neurovascular devices market.
- To classify and forecast the global neurovascular devices market based on product, application, end user, region.
- To identify drivers and challenges for the global neurovascular devices market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global neurovascular devices market.
- To identify and analyze the profile of leading players operating in the global neurovascular devices market.

Why Choose This Report
- Gain a reliable outlook of the global neurovascular devices market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.

Content
TABLE OF CONTENTS

FIGURES AND TABLES
PART 1. INTRODUCTION
· Report description
· Objectives of the study
· Market segment
· Years considered for the report
· Currency
· Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
· Introduction
· Drivers
· Restraints
· Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY PRODUCT
· Access devices (microcatheter, guidewire)
· Angioplasty and stenting (carotid stenting, embolic protection systems)
· Embolization devices (embolic coils, flow diverter, liquid embolic agent)
· Thrombectomy devices (clot retrieval devices, suction & aspiration devices, snares)
PART 6. MARKET BREAKDOWN BY APPLICATION
· Arteriovenous malformation and fistulas (AVM)
· Cerebral aneurysm
· Cerebral artery stenosis
· Ischemic strokes
· Others
PART 7. MARKET BREAKDOWN BY END USER
· Ambulatory surgical centers (ASCs)
· Hospitals
· Specialized clinics
PART 8. MARKET BREAKDOWN BY REGION
· Asia Pacific
· Europe
· North America
· Rest of the World (RoW)
PART 9. KEY COMPANIES
· EndoVasix Inc.
· Johnson & Johnson
· Medtronic plc
· MicroPort Scientific Corporation
· MIVI Neuroscience, Inc.
· Oxford Endovascular Limited
· Penumbra, Inc.
· Rapid Medical Ltd.
· Stryker Corporation
· Terumo Corporation
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER